Sep 3, 2025 06:44AM Annovis Bio Inc. (ANVS) PT Lowered to $10 at H.C. Wainwright

Aug 12, 2025 05:41PM Annovis Bio, Inc. (ANVS) Tops Q2 EPS by 8c

Aug 7, 2025 08:00AM Annovis Bio completes patent transfer for crystalline buntanetap

Jun 9, 2025 06:38AM Annovis Bio Inc. (ANVS) PT Lowered to $12 at H.C. Wainwright

May 15, 2025 06:42AM Annovis Bio Inc. (ANVS) PT Lowered to $17 at Canaccord Genuity

May 13, 2025 06:24PM Annovis Bio, Inc. (ANVS) Tops Q1 EPS by 6c

Apr 29, 2025 08:05AM Annovis Bio Inc. (ANVS) Appoints Hui Liu as Director of Biostatistics

Mar 27, 2025 04:31PM Annovis Bio Inc. (ANVS) Receives Nasdaq Non-compliance Notice

Feb 10, 2025 07:26AM D. Boral Capital Downgrades Annovis Bio Inc. (ANVS) to Hold

Feb 5, 2025 08:01AM Annovis Bio Inc. (ANVS) Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease

Feb 4, 2025 04:31PM Annovis Bio Inc. (ANVS) Closes $21M Offering

Feb 3, 2025 06:23AM Annovis Bio Inc. (ANVS) Prices 5.25M Share Offering at $4/sh

Jan 14, 2025 08:01AM Annovis Bio (ANVS) Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

Jan 7, 2025 08:01AM Annovis Bio Inc. (ANVS) Announces FDA Acceptance of Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study

Jan 7, 2025 08:00AM Annovis Bio Inc. (ANVS) FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway

Dec 11, 2024 07:26AM Annovis Bio Inc. (ANVS) enters Equity Distribution Agreement

Nov 11, 2024 10:08AM Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c

Nov 7, 2024 08:05AM Annovis Bio Inc. (ANVS) Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist

Oct 16, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Annovis Bio Inc. (ANVS)

Oct 15, 2024 08:03AM Annovis Bio Inc. (ANVS): FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs

Oct 1, 2024 07:04AM H.C. Wainwright Reiterates Buy Rating on Annovis Bio Inc. (ANVS)

Sep 30, 2024 08:05AM Annovis Bio Inc. (ANVS) Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

Sep 3, 2024 07:22AM Canaccord Genuity Reiterates Buy Rating on Annovis Bio Inc. (ANVS)

Aug 13, 2024 07:02AM EF Hutton Starts Annovis Bio Inc. (ANVS) at Buy

Jul 16, 2024 08:01AM Annovis Bio (ANVS) Receives FDA Approval to Transition to New Crystal Form of Buntanetap

Jul 12, 2024 06:38AM Annovis Bio Inc. (ANVS) PT Raised to $30 at H.C. Wainwright

Jul 2, 2024 08:04AM Annovis Bio Inc. (ANVS) Announces New Data from Phase III Parkinson’s Study

Jun 26, 2024 08:00AM Annovis Bio (ANVS) Files Patent for New Composition of Matter for Buntanetap